Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China's state council demands raised quality for "essential drugs"

This article was originally published in SRA

Executive Summary

Officials at the highest level of China's government have said that the quality of medicines on China's essential drugs list must be raised to international standards, a move that challenges the existing essential drugs scheme in the country1.

You may also be interested in...



FDA nod for first 'made in China' MAb

China is known for a global supplier of active pharmaceutical ingredients, but with continuous investment in advanced facilities and talents, it is likely to be a global supplier of biological therapies. The US approval of a 'made in China' monoclonal antibody for use in clinical trials marks a milestone in China's journey.

Fosun licenses novel TB treatment for China

Shanghai-based, Hong Kong and Shanghai listed Fosun Pharmaceutical has been busy adding foreign assets under its belt.

China’s state council demands raised quality for ‘essential drugs’

Officials at the highest level of China’s government have said that the quality of medicines on China’s essential drugs list must be raised to international standards, a move that challenges the existing essential drugs scheme in the country.

UsernamePublicRestriction

Register

PS117215

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel